Sunshine Act Meetings, 43900-43901 [2018-18660]
Download as PDF
daltland on DSKBBV9HB2PROD with NOTICES
43900
Federal Register / Vol. 83, No. 167 / Tuesday, August 28, 2018 / Notices
Advanced Micro Devices, Inc. of
Sunnyvale, California and ATI
Technologies ULC of Canada
(collectively, ‘‘AMD’’ or
‘‘Complainants’’). See 82 FR 14748
(Mar. 22, 2017). The complaint, as
amended, alleges violations of section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), based upon
the importation into the United States,
the sale for importation, and the sale
within the United States after
importation of certain graphics systems,
components thereof, and consumer
products containing the same, by reason
of infringement of certain claims of the
’506 patent; U.S. Patent No. 7,796,133
(‘‘the ’133 patent’’); U.S. Patent No.
8,760,454 (‘‘the ’454 patent’’); and U.S.
Patent No. 9,582,846 (‘‘the ’846 patent’’).
Id. The notice of investigation identified
LG Electronics, Inc. of Seoul, Republic
of Korea, LG Electronics U.S.A., Inc. of
Englewood Cliffs, New Jersey, and LG
Electronics MobileComm U.S.A. Inc. of
San Diego, California (collectively,
‘‘LG’’), VIZIO of Irvine, California,
MediaTek Inc. of Hsinchu City, Taiwan
and Media Tek USA Inc. of San Jose,
California (collectively, ‘‘MediaTek’’),
and SDI of Fremont, California, as
respondents in this investigation. See
id. The Office of Unfair Import
Investigations (‘‘OUII’’) is also a party to
the investigation.
On October 20, 2017, the ALJ issued
an initial determination terminating the
investigation as to LG based on
settlement. See Order No. 48 (Oct. 20,
2017), unreviewed, Comm’n Notice
(Nov. 13, 2017). The remaining
respondents in this investigation are
VIZIO, MediaTek, and SDI (hereinafter,
‘‘the Remaining Respondents’’). The ALJ
also terminated the investigation with
respect to all asserted claims of the ’454
and ’846 patents; claims 6, 7, and 9 of
the ’506 patent; and claims 2, 4–13, and
40 of the ’133 patent. See Order No. 33
(Aug. 15, 2017), unreviewed, Comm’n
Notice (Sept. 5, 2017); Order No. 43
(Oct. 5, 2017), unreviewed, Comm’n
Notice (Oct. 31, 2017); Order No. 49
(Oct. 20, 2017), unreviewed, Comm’n
Notice (Nov. 13, 2017); Order No. 53
(Oct. 31, 2017), unreviewed, Comm’n
Notice (Nov. 28, 2017). Claims 1–5 and
8 of the ’506 patent and claims 1 and 3
of the ’133 patent (hereinafter, ‘‘the
asserted claims’’) remain pending in this
investigation.
On April 13, 2018, the ALJ issued her
final Initial Determination (‘‘FID’’) and
Recommended Determination on
Remedy and Bond (‘‘RD’’) finding a
violation of section 337 with respect to
the ’506 patent but not the ’133 patent.
Specifically, the FID finds that: (1)
Certain accused products infringe the
VerDate Sep<11>2014
20:00 Aug 27, 2018
Jkt 244001
asserted claims of the ’506 patent but
not the ’133 patent; (2) the asserted
claims are not invalid; and (3)
Complainants satisfy the economic and
technical prongs of the domestic
industry requirement with respect to
both asserted patents. In addition, the
ALJ recommended that the Commission
issue: (1) A Limited Exclusion Order
against the infringing accused products;
and (2) Cease and Desist Orders against
Respondents VIZIO and SDI. The ALJ
further recommended against setting a
bond during Presidential review.
On June 14, 2018, the Commission
issued a Notice determining to review
the FID in part. See 83 FR 28660–62
(June 20, 2018). The Commission sought
written submissions in response to
certain questions relating to the claim
construction of the terms ‘‘unified
shader’’ (recited in the ’506 and ’133
patent claims), ‘‘packet’’ (recited in the
’133 patent claims), and ‘‘ALU/memory
pair’’ (recited in the ’133 patent claims).
See id. The Commission also solicited
written submissions on the issues of
remedy, the public interest, and
bonding. See id. On June 28, 2018, the
parties filed written submissions in
response to the June 14, 2018 Notice,
and on July 6, 2018, the parties filed
responses to each other’s submissions.
On June 26, 2018, Complainants filed
a motion for leave to amend the
complaint and notice of investigation to
add V-Silicon Inc. and V-Silicon
International, Inc. as respondents in this
investigation (Motion). On July 5 and 6,
2018, OUII and Respondents,
respectively, filed responses to
Complainants’ motion to amend. As
explained in the Commission’s Opinion
issued concurrently herewith, the
Commission has determined to deny
Complainants’ Motion.
In addition, having examined the
record of this investigation, including
the FID, the RD, and the parties’
submissions, the Commission has
determined to affirm the FID’s ultimate
conclusions of a section 337 violation
with respect to the ’506 patent and no
section 337 violation with respect to the
’133 patent. In addition, the
Commission has determined to modify
the FID in part with respect to: (1) The
importation requirement as to
Respondents MediaTek and SDI; and (2)
the claim construction of the terms
‘‘unified shader,’’ ‘‘packet,’’ and ‘‘ALU/
memory pair’’ as well as certain related
FID findings on infringement, validity,
and the technical prong of the domestic
industry requirement. All findings in
the FID that are not inconsistent with
the Commission’s determination are
affirmed.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Accordingly, the Commission finds
that there is a violation of section 337
with respect to the ’506 patent. The
Commission has determined that the
appropriate remedy is a limited
exclusion order against Respondents’
infringing products, and cease and
desist orders against Respondents VIZIO
and SDI. The Commission has also
determined that the public interest
factors enumerated in subsections
337(d)(l) and (f)(1) (19 U.S.C. 1337(d)(l),
(f)(1)) do not preclude the issuance of
the limited exclusion order and cease
and desist orders. The Commission has
further determined to set a bond at zero
(0) percent of entered value during the
Presidential review period (19 U.S.C.
1337(j)).
The Commission’s orders and opinion
were delivered to the President and to
the United States Trade Representative
on the day of their issuance.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: August 22, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018–18569 Filed 8–27–18; 8:45 am]
BILLING CODE 7020–02–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2018–0001]
Sunshine Act Meetings
Weeks of August 27,
September 3, 10, 17, 24, October 1,
2018.
PLACE: Commissioners’ Conference
Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS: Public and Closed.
MATTERS TO BE CONSIDERED:
TIME AND DATE:
Week of August 27, 2018
There are no meetings scheduled for
the week of August 27, 2018.
Week of September 3, 2018—Tentative
There are no meetings scheduled for
the week of September 3, 2018.
Week of September 10, 2018—Tentative
Monday, September 10, 2018
10:00 a.m. Briefing on NRC
International Activities (Closed—Ex. 1
& 9).
E:\FR\FM\28AUN1.SGM
28AUN1
Federal Register / Vol. 83, No. 167 / Tuesday, August 28, 2018 / Notices
Week of September 17, 2018—Tentative
There are no meetings scheduled for
the week of September 17, 2018.
Week of September 24, 2018—Tentative
Thursday, September 27, 2018
10:00 a.m. Strategic Programmatic
Overview of the Operating Reactors
Business Line (Public), (Contact: Trent
Wertz: 01–415–1568).
This meeting will be webcast live at
the web address—https://www.nrc.gov/.
Week of October 1, 2018—Tentative
There are no meetings scheduled for
the week of October 1, 2018.
CONTACT PERSON FOR MORE INFORMATION:
daltland on DSKBBV9HB2PROD with NOTICES
For more information or to verify the
status of meetings, contact Denise
McGovern at 301–415–0681 or via email
at Denise.McGovern@nrc.gov. The
schedule for Commission meetings is
subject to change on short notice.
The NRC Commission Meeting
Schedule can be found on the internet
at: https://www.nrc.gov/public-involve/
public-meetings/schedule.html.
The NRC provides reasonable
accommodation to individuals with
disabilities where appropriate. If you
need a reasonable accommodation to
participate in these public meetings, or
need this meeting notice or the
transcript or other information from the
public meetings in another format (e.g.,
braille, large print), please notify
Kimberly Meyer-Chambers, NRC
Disability Program Manager, at 301–
287–0739, by videophone at 240–428–
3217, or by email at Kimberly.MeyerChambers@nrc.gov. Determinations on
requests for reasonable accommodation
will be made on a case-by-case basis.
Members of the public may request to
receive this information electronically.
If you would like to be added to the
distribution, please contact the Nuclear
Regulatory Commission, Office of the
Secretary, Washington, DC 20555 (301–
415–1969), or you may email
Patricia.Jimenez@nrc.gov or
Wendy.Moore@nrc.gov.
Dated: August 23, 2018.
Denise L. McGovern,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2018–18660 Filed 8–24–18; 11:15 am]
BILLING CODE 7590–01–P
VerDate Sep<11>2014
20:00 Aug 27, 2018
Jkt 244001
DC 20555–0001; telephone: 301–415–
1384; email: Janet.Burkhardt@nrc.gov.
SUPPLEMENTARY INFORMATION:
NUCLEAR REGULATORY
COMMISSION
[NRC–2018–0181]
Biweekly Notice; Applications and
Amendments to Facility Operating
Licenses and Combined; Licenses
Involving No Significant Hazards
Considerations
Nuclear Regulatory
Commission.
ACTION: Biweekly notice.
AGENCY:
Pursuant to the Atomic
Energy Act of 1954, as amended (the
Act), the U.S. Nuclear Regulatory
Commission (NRC) is publishing this
regular biweekly notice. The Act
requires the Commission to publish
notice of any amendments issued, or
proposed to be issued, and grants the
Commission the authority to issue and
make immediately effective any
amendment to an operating license or
combined license, as applicable, upon a
determination by the Commission that
such amendment involves no significant
hazards consideration, notwithstanding
the pendency before the Commission of
a request for a hearing from any person.
This biweekly notice includes all
notices of amendments issued, or
proposed to be issued, from July 31,
2018, to August 13, 2018. The last
biweekly notice was published on
August 14, 2018.
DATES: Comments must be filed by
September 27, 2018. A request for a
hearing must be filed by October 29,
2018.
SUMMARY:
You may submit comments
by any of the following methods:
• Federal Rulemaking website: Go to
https://www.regulations.gov and search
for Docket ID NRC–2018–0181. Address
questions about NRC dockets to Jennifer
Borges; telephone: 301–287–9127;
email: Jennifer.Borges@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• Mail comments to: May Ma, Office
of Administration, Mail Stop: TWFN–7–
A60M, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001.
For additional direction on obtaining
information and submitting comments,
see ‘‘Obtaining Information and
Submitting Comments’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT:
Janet Burkhardt, Office of Nuclear
Reactor Regulation, U.S. Nuclear
Regulatory Commission, Washington,
ADDRESSES:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
43901
I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2018–
0181, facility name, unit number(s),
plant docket number, application date,
and subject when contacting the NRC
about the availability of information for
this action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal Rulemaking website: Go to
https://www.regulations.gov and search
for Docket ID NRC–2018–0181.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–4209, 301–
415–4737, or by email to pdr.resource@
nrc.gov. The ADAMS accession number
for each document referenced (if it is
available in ADAMS) is provided the
first time that it is mentioned in this
document.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
B. Submitting Comments
Please include Docket ID NRC–2018–
0181, facility name, unit number(s),
plant docket number, application date,
and subject in your comment
submission.
The NRC cautions you not to include
identifying or contact information that
you do not want to be publicly
disclosed in your comment submission.
The NRC will post all comment
submissions at https://
www.regulations.gov as well as enter the
comment submissions into ADAMS.
The NRC does not routinely edit
comment submissions to remove
identifying or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the NRC, then you should
inform those persons not to include
identifying or contact information that
they do not want to be publicly
disclosed in their comment submission.
Your request should state that the NRC
does not routinely edit comment
submissions to remove such information
E:\FR\FM\28AUN1.SGM
28AUN1
Agencies
[Federal Register Volume 83, Number 167 (Tuesday, August 28, 2018)]
[Notices]
[Pages 43900-43901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-18660]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2018-0001]
Sunshine Act Meetings
TIME AND DATE: Weeks of August 27, September 3, 10, 17, 24, October 1,
2018.
PLACE: Commissioners' Conference Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS: Public and Closed.
MATTERS TO BE CONSIDERED:
Week of August 27, 2018
There are no meetings scheduled for the week of August 27, 2018.
Week of September 3, 2018--Tentative
There are no meetings scheduled for the week of September 3, 2018.
Week of September 10, 2018--Tentative
Monday, September 10, 2018
10:00 a.m. Briefing on NRC International Activities (Closed--Ex. 1
& 9).
[[Page 43901]]
Week of September 17, 2018--Tentative
There are no meetings scheduled for the week of September 17, 2018.
Week of September 24, 2018--Tentative
Thursday, September 27, 2018
10:00 a.m. Strategic Programmatic Overview of the Operating
Reactors Business Line (Public), (Contact: Trent Wertz: 01-415-1568).
This meeting will be webcast live at the web address--https://www.nrc.gov/.
Week of October 1, 2018--Tentative
There are no meetings scheduled for the week of October 1, 2018.
CONTACT PERSON FOR MORE INFORMATION: For more information or to verify
the status of meetings, contact Denise McGovern at 301-415-0681 or via
email at [email protected]. The schedule for Commission meetings
is subject to change on short notice.
The NRC Commission Meeting Schedule can be found on the internet
at: https://www.nrc.gov/public-involve/public-meetings/schedule.html.
The NRC provides reasonable accommodation to individuals with
disabilities where appropriate. If you need a reasonable accommodation
to participate in these public meetings, or need this meeting notice or
the transcript or other information from the public meetings in another
format (e.g., braille, large print), please notify Kimberly Meyer-
Chambers, NRC Disability Program Manager, at 301-287-0739, by
videophone at 240-428-3217, or by email at [email protected]. Determinations on requests for reasonable
accommodation will be made on a case-by-case basis.
Members of the public may request to receive this information
electronically. If you would like to be added to the distribution,
please contact the Nuclear Regulatory Commission, Office of the
Secretary, Washington, DC 20555 (301-415-1969), or you may email
[email protected] or [email protected].
Dated: August 23, 2018.
Denise L. McGovern,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2018-18660 Filed 8-24-18; 11:15 am]
BILLING CODE 7590-01-P